Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AmBisome, Miltefosine, and SSG Combinations for Visceral Leishmaniasis
NCT01067443Phase 2Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Mar 2010
- Primary completion
- Jun 2011
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of miltefosine in visceral leishmaniasis (VL), sponsored by Drugs for Neglected Diseases initiative. Started Mar 2010; status: completed.
02
Drugs
miltefosine
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT01067443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067443.